BioXcel Therapeutics Announces Pricing of $7.0 Million Public …

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, …


Install CouponFollow Chrome Extension   CouponFollow Extension

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, …

bioxceltherapeutics.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

1 day ago  · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial …

yahoo.com

$7
OFF

2024-11-22 | BioXcel Therapeutics Announces Pricing Of $7.0 …

6 days from now

1 day ago  · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company …

stockhouse.com

$7
OFF

BTAI - BioXcel Therapeutics Announces Pricing Of $7.0...

6 days from now

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence …

marketwirenews.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

1 day ago  · Each of the accompanying warrants will have an exercise price of $0.48 per underlying share of Common Stock. Canaccord Genuity is acting as sole book-running …

einnews.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public Of

6 days from now

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the â Companyâ ) ( BTAI), a biopharmaceutical company utilizing artificial i 🚀 Enjoy a 7-Day Free …

gurufocus.com

$7
OFF

BioXcel Therapeutics (BTAI) Announces Pricing Of $7.0 Million …

6 days from now

1 day ago  · BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in …

streetinsider.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

23 hours ago  · BioXcel Therapeutics (NASDAQ:BTAI) on Friday announced the pricing of an underwritten public offering of 5.6M shares of its common stock and accompanying warrants …

seekingalpha.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

1 day ago  · BioXcel Therapeutics (BTAI) has announced the pricing of a $7.0 million public offering, consisting of 5,600,000 shares of common stock and warrants to purchase up to …

stocktitan.net

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

BioXcel Therapeutics (NASDAQ:BTAI) on Friday announced the pricing of an underwritten public offering of 5.6M shares of its common stock and accompanying warrants to purchase up to …

msn.com

$0.00
OFF

BioXcel Therapeutics Prices 5.6M Shares At 48c In Public Offering

6 days from now

1 day ago  · BioXcel Therapeutics (BTAI) announced the pricing of an underwritten public offering of 5,600,000 shares of its common stock, par value $0.001 per share and accompanying …

businessinsider.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million

6 days from now

1 day ago  · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial …

globenewswire.com

1%
OFF

BioXcel Therapeutics (BTAI) Announces Proposed Public Offering

6 days from now

1 day ago  · Oil prices settle up 1% at 2-week high as Ukraine war intensifies Bitcoin approaches $100,000 on optimism over Trump crypto plans Palo Alto Networks (PANW) Announces 2:1 …

streetinsider.com

89%
OFF

BioXcel Therapeutics Inc (BTAI) Q3 2024 Earnings Call Highlights ...

6 days from now

Nov 15, 2024  · BioXcel Therapeutics Inc (NASDAQ:BTAI) reported an 89% increase in net revenue for the nine months ended September 30, 2024, compared to the same period in …

yahoo.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

23 hours ago  · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the "Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing …

manilatimes.net

$0.21
OFF

BioXcel Therapeutics (BTAI) Stock Price, News & Analysis

6 days from now

3 days ago  · BioXcel Therapeutics, Inc. (NASDAQ:BTAI) announced its earnings results on Tuesday, August, 6th. The company reported ($0.21) earnings per share (EPS) for the …

marketbeat.com

FAQs about BioXcel Therapeutics Announces Pricing of $7.0 Million Public … Coupon?

Who owns bioxcel Therapeutics (btai)?

It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT. View BioXcel Therapeutics, Inc. BTAI stock quote prices, financial information, real-time forecasts, and company news from CNN. ...

Is bioxcel Therapeutics a biopharmaceutical company?

NEW HAVEN, Conn., Nov. 14, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced its financial results for the third quarter of 2024. ...

What time will bioxcel Therapeutics' financial results be released?

Conferencecallset for 8:00a.m.ETtoday NEW HAVEN, Conn., Nov. 14, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced its financial results for the third quarter of 2024. ...

Does bioxcel Therapeutics (btai) have earnings?

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) reported earnings on Thursday, May, 9th. The company reported ($0.87) EPS, missing analysts' consensus estimates of ($0.68) by $0.19. The business earned $0.58 million during the quarter, compared to the consensus estimate of $0.42 million. ...

How much cash did bioxcel Therapeutics use in third quarter 2024?

The Company used $16.3 million in operating cash during the third quarter of 2024. Cash and cash equivalents totaled $40.4 million as of September 30, 2024. BioXcel Therapeutics will host a conference call and webcast today, November 14, 2024, at 8:00 a.m. ET to discuss its third quarter 2024 financial results. ...

How much did bioxcel Therapeutics raise in an IPO?

BioXcel Therapeutics (BTAI) raised $60 million in their IPO on Thursday, March 8th 2018. The company issued 5,000,000 shares at a price of $11.00-$13.00 per share. $60 million was raised in the IPO. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension